Symjepi: A new option for injectable epinephrineSandoz Pharmaceuticals announced the introduction of Symjepi, a prefilled epinephrine syringe for the emergency treatment of severe allergic reactions. The Symjepi device is the fifth epinephrine injector on the market, joining EpiPen, the Epi-Pen authorized generic, Adrenaclick and Auvi-Q. Unlike the others, Symjepi is a manual syringe, rather than an autoinjector. While the first impression might be that an automatic injector would be better than having to inject epinephrine manually into the thigh, one study showed that it might not be a bad thing.
In the study, teenagers were given both Symjepi and Epi-Pen and were asked to demonstrate using them without any training. The scenario simulated a real-world emergency...
Posted on March 18, 2019 Read more...
Wixela: Generic version of Advair now approvedMylan Pharmaceuticals announced that the FDA approved their new Wixela inhalers (the generic versions of Advair). The wholesale cost of Wixela is less than half the cost of Advair, so we will hopefully see some of the price relief we have long needed in the treatment of asthma! If you are looking for a less expensive option, we recommend first talking with your allergist about whether switching might be appropriate for you. Next, you will want to call your insurance company to ask about what your copay will be.
Much like the Advair Diskus, Wixela is a dry powder inhaler. The device is a little different, with the disc part...
The above posts and many other topics can be viewed on our News Page
